These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 11037883
1. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene. Ihn H, Tamaki K. Arthritis Rheum; 2000 Oct; 43(10):2240-7. PubMed ID: 11037883 [Abstract] [Full Text] [Related]
3. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors. Ihn H, Yamane K, Kubo M, Tamaki K. Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480 [Abstract] [Full Text] [Related]
4. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Saitta B, Gaidarova S, Cicchillitti L, Jimenez SA. Arthritis Rheum; 2000 Oct; 43(10):2219-29. PubMed ID: 11037881 [Abstract] [Full Text] [Related]
5. Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Hitraya EG, Varga J, Artlett CM, Jiménez SA. Arthritis Rheum; 1998 Nov; 41(11):2048-58. PubMed ID: 9811061 [Abstract] [Full Text] [Related]
9. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753 [Abstract] [Full Text] [Related]
10. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M. Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427 [Abstract] [Full Text] [Related]
11. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta. Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J. Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659 [Abstract] [Full Text] [Related]
12. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma. Pannu J, Gardner H, Shearstone JR, Smith E, Trojanowska M. Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635 [Abstract] [Full Text] [Related]
14. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors. Heegaard AM, Xie Z, Young MF, Nielsen KL. J Cell Biochem; 2004 Oct 15; 93(3):463-75. PubMed ID: 15372625 [Abstract] [Full Text] [Related]
15. Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts. Jinnin M, Ihn H, Mimura Y, Asano Y, Tamaki K. Biochem Biophys Res Commun; 2006 May 12; 343(3):904-9. PubMed ID: 16564026 [Abstract] [Full Text] [Related]
17. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N. Arthritis Rheum; 2004 Jan 12; 50(1):216-26. PubMed ID: 14730619 [Abstract] [Full Text] [Related]
18. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Louneva N, Huaman G, Fertala J, Jiménez SA. Arthritis Rheum; 2006 Apr 12; 54(4):1298-308. PubMed ID: 16575855 [Abstract] [Full Text] [Related]